España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Celularity
CELU
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$3.55
0.46
14.89%
At close: -
$3.69
0.14
3.94%
After Hours: 7:59 PM EDT
Get Report
Comment
Q2 2024 Earnings were released on Thu Nov 7th, before the market open
Celularity (CELU) Forecast
News
Earnings
Celularity (CELU) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Celularity (NASDAQ:CELU) Stock
Celularity Stock (NASDAQ: CELU)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, November 07, 2024
Celularity Shares Resume Trading
Benzinga Newsdesk
Celularity Shares Resume Trade And Quickly Ha...
Benzinga Newsdesk
Celularity Shares Halted To The Upside; Stock...
Benzinga Newsdesk
Celularity shares are trading higher after th...
Benzinga Newsdesk
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Celularity Raises FY24 Expected Net Sales Gui...
Benzinga Newsdesk
Wednesday, October 23, 2024
Celularity Files Appeal Request And Amended C...
Benzinga Newsdesk
Tuesday, October 22, 2024
Celularity Intends To File Form 10-Q For Q2 2...
Benzinga Newsdesk
Celularity Provides Corporate Update; Says Th...
Benzinga Newsdesk
Friday, October 18, 2024
Celularity Receives Notice From Nasdaq; Confi...
Benzinga Newsdesk
Wednesday, October 16, 2024
Celularity Acquires Rebound, A Placental-deri...
Benzinga Newsdesk
Wednesday, July 31, 2024
Celularity FY23 Revenue Of $22.8M; Sees Q1 R...
Benzinga Newsdesk
Monday, June 03, 2024
Celularity Presents Data On T-Cell Therapy Pl...
Benzinga Newsdesk
Wednesday, May 15, 2024
Celularity Granted European Patent EP3957315 ...
Benzinga Newsdesk
Tuesday, May 14, 2024
Celularity's Published Data In 'Journal For I...
Benzinga Newsdesk
Monday, April 15, 2024
Celularity Says That Its Expected Net Sales F...
Benzinga Newsdesk
Monday, April 08, 2024
Celularity To Present Data Showing Senescent ...
Benzinga Newsdesk
Tuesday, March 26, 2024
Celularity Receives Healthcare Common Procedu...
Benzinga Newsdesk
Wednesday, March 20, 2024
Celularity Submits Request To US FDA For Orph...
Benzinga Newsdesk
Wednesday, March 13, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Thursday, February 29, 2024
Trading Halt: Halt status updated at 8:55:00 ...
Benzinga Newsdesk
Trading Halt: Halted at 7:50:00 p.m. ET - Tra...
Benzinga Newsdesk
Monday, February 26, 2024
Workday, Domino's And 3 Stocks To Watch Heading Into Monday
Avi Kapoor
Friday, February 23, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Celularity Announces 1-For-10 Reverse Stock S...
Benzinga Newsdesk
Wednesday, February 14, 2024
Celularity's Tri-layer Decellularized, Dehydrated Human Amniotic Membrane Product Investigated As A Carrier Of Induced Pluripotent Stem Cell Derived-Limbal Stem Cells In The Treatment Of Severe Ocular Surface Disease
Happy Mohamed
Friday, February 09, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Friday, February 02, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Thursday, February 01, 2024
Dow Jumps 250 Points; Honeywell Issues Weak Forecast
Avi Kapoor
Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
Celularity shares are trading higher after th...
Benzinga Newsdesk
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Crude Oil Gains 1%; ISM Manufacturing PMI Tops Expectations
Avi Kapoor
Celularity Sees FY24 Net Sales $50M-$56M
Benzinga Newsdesk
Celularity Sees Q1 2024 Net Sales $10.25M-$11...
Benzinga Newsdesk
Tuesday, January 30, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Wednesday, January 24, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Monday, January 22, 2024
Why Coherus BioSciences Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Thursday, January 18, 2024
Celularity shares are trading higher after th...
Benzinga Newsdesk
Celularity Releases CEO Letter To Shareholder...
Benzinga Newsdesk
Why KeyCorp Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Nasdaq Jumps Over 100 Points; US Jobless Claims Fall To 187,000
Avi Kapoor
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Why M.D.C. Holdings Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Wednesday, January 03, 2024
BioCellgraft Finalized Commercialization Agreement with Celularity For The Manufacture and Distribution of Products for Therapeutic Use in Oral Healthcare
Charles Gross
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Celularity Anticipates That It Will Announce ...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch